标题
Protein Biomarkers and Risk of Atrial Fibrillation
作者
关键词
-
出版物
Circulation-Arrhythmia and Electrophysiology
Volume 13, Issue 2, Pages -
出版商
Ovid Technologies (Wolters Kluwer Health)
发表日期
2020-01-16
DOI
10.1161/circep.119.007607
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Relation of IGF-1 and IGFBP-3 with prevalent and incident atrial fibrillation in a population-based study
- (2019) Mathias Busch et al. HEART RHYTHM
- Comparison of Prognostic Usefulness of Serum Insulin-Like Growth Factor-Binding Protein 7 in Patients With Heart Failure and Preserved Versus Reduced Left Ventricular Ejection Fraction
- (2018) Camilla Hage et al. AMERICAN JOURNAL OF CARDIOLOGY
- Lifetime Risk of Atrial Fibrillation by Race and Socioeconomic Status
- (2018) Liping Mou et al. Circulation-Arrhythmia and Electrophysiology
- Lifetime risk of atrial fibrillation according to optimal, borderline, or elevated levels of risk factors: cohort study based on longitudinal data from the Framingham Heart Study
- (2018) Laila Staerk et al. BMJ-British Medical Journal
- Lifetime risk of atrial fibrillation according to optimal, borderline, or elevated levels of risk factors: cohort study based on longitudinal data from the Framingham Heart Study
- (2018) Laila Staerk et al. BMJ-British Medical Journal
- Protein Biomarkers of Cardiovascular Disease and Mortality in the Community
- (2018) Jennifer E. Ho et al. Journal of the American Heart Association
- Data-driven discovery and validation of circulating blood-based biomarkers associated with prevalent atrial fibrillation
- (2018) Winnie Chua et al. EUROPEAN HEART JOURNAL
- Impact of atrial fibrillation on platelet gene expression
- (2017) Waldemar E. Wysokinski et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Serum Insulin-Like Growth Factor 1 and the Risk of Ischemic Stroke
- (2017) Hamidreza Saber et al. STROKE
- Genetic Predisposition, Clinical Risk Factor Burden, and Lifetime Risk of Atrial Fibrillation
- (2017) Lu-Chen Weng et al. CIRCULATION
- Interaction between fibrinogen and insulin-like growth factor-binding protein-1 in human plasma under physiological conditions
- (2016) N. Gligorijević et al. BIOCHEMISTRY-MOSCOW
- Discovery of new biomarkers for atrial fibrillation using a custom-made proteomics chip
- (2016) Lars Lind et al. HEART
- Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis
- (2016) Ayodele Odutayo et al. BMJ-British Medical Journal
- Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis
- (2016) Ayodele Odutayo et al. BMJ-British Medical Journal
- Insulin-like growth factor I reduces lipid oxidation and foam cell formation via downregulation of 12/15-lipoxygenase
- (2015) Sergiy Sukhanov et al. ATHEROSCLEROSIS
- 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study
- (2015) Renate B Schnabel et al. LANCET
- Protein Biomarkers of New-Onset Cardiovascular Disease
- (2014) Xiaoyan Yin et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- B-type natriuretic peptide and C-reactive protein in the prediction of atrial fibrillation risk: the CHARGE-AF Consortium of community-based cohort studies
- (2014) Moritz F. Sinner et al. EUROPACE
- The small-molecule BGP-15 protects against heart failure and atrial fibrillation in mice
- (2014) Geeta Sapra et al. Nature Communications
- Relation between soluble ST2, growth differentiation factor–15, and high-sensitivity troponin I and incident atrial fibrillation
- (2013) Michiel Rienstra et al. AMERICAN HEART JOURNAL
- Insulin-Like Growth Factor I, Insulin-like Growth factor Binding Protein 3, and Atrial Fibrillation in the Elderly
- (2013) E. Duron et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- Simple Risk Model Predicts Incidence of Atrial Fibrillation in a Racially and Geographically Diverse Population: the CHARGE‐AF Consortium
- (2013) Alvaro Alonso et al. Journal of the American Heart Association
- Cardiac Aging: From Molecular Mechanisms to Significance in Human Health and Disease
- (2012) Dao-Fu Dai et al. ANTIOXIDANTS & REDOX SIGNALING
- Differential requirement for nitric oxide in IGF-1-induced anti-apoptotic, anti-oxidant and anti-atherosclerotic effects
- (2011) Sergiy Sukhanov et al. FEBS LETTERS
- Circulating levels of insulin-like growth factor binding protein–1 in relation to insulin resistance, type 2 diabetes mellitus, and metabolic syndrome (Chennai Urban Rural Epidemiology Study 118)
- (2011) Kuppan Gokulakrishnan et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Growth Factor-Induced Mobilization of Cardiac Progenitor Cells Reduces the Risk of Arrhythmias, in a Rat Model of Chronic Myocardial Infarction
- (2011) Leonardo Bocchi et al. PLoS One
- Circulating Insulin-Like Growth Factor-1 and Its Binding Protein-3
- (2010) Carolyn S.P. Lam et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Relations of Biomarkers of Distinct Pathophysiological Pathways and Atrial Fibrillation Incidence in the Community
- (2010) Renate B. Schnabel et al. CIRCULATION
- IGF-1, oxidative stress and atheroprotection
- (2010) Yusuke Higashi et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Insulin-like growth factor binding protein: a possible marker for the metabolic syndrome?
- (2009) Wenjing Ruan et al. ACTA DIABETOLOGICA
- Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study
- (2009) Renate B Schnabel et al. LANCET
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started